Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
์ข
๋ชฉ ์ฝ๋ RGC
ํ์ฌ ์ด๋ฆRegencell Bioscience Holdings Ltd
์์ฅ์ผJul 16, 2021
CEO- -
์ง์ ์12
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃJul 16
์ฃผ์11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay
๋์
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐHong Kong
์ฐํธ ๋ฒํธ- -
์ ํ85221550823
์น์ฌ์ดํธhttps://www.regencellbioscience.com/
์ข
๋ชฉ ์ฝ๋ RGC
์์ฅ์ผJul 16, 2021
CEO- -
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์